🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
313,52 USD
Máx. histórico
322,75
4 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-2,86%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,12%
Cierre anterior
307,02
Rango de hoy
309,46 – 317,76
Volumen hoy
195.564
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 33,04 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 350,92 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 4 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 21/06/1993 | 36,49 | 36,49 | 36,49 | 36,49 | +8,33% | 0,00% | 1.763 |
| 18/06/1993 | 33,69 | 33,69 | 33,69 | 33,69 | +2,86% | 0,00% | 347 |
| 17/06/1993 | 32,75 | 36,49 | 32,75 | 32,75 | -10,26% | 11,43% | 240 |
| 16/06/1993 | 33,69 | 36,49 | 32,75 | 36,49 | +11,43% | 11,11% | 2.271 |
| 15/06/1993 | 32,75 | 33,69 | 32,75 | 32,75 | -4,11% | 2,86% | 3.340 |
| 14/06/1993 | 32,75 | 35,56 | 32,75 | 34,15 | -3,95% | 8,57% | 748 |
| 11/06/1993 | 35,56 | 35,56 | 32,75 | 35,56 | +0,00% | 7,89% | 214 |
| 10/06/1993 | 33,69 | 35,56 | 32,75 | 35,56 | +0,00% | 8,33% | 16.751 |
| 09/06/1993 | 33,69 | 35,56 | 33,69 | 35,56 | +2,70% | 5,56% | 2.137 |
| 08/06/1993 | 34,62 | 36,03 | 33,69 | 34,62 | +0,00% | 6,76% | 1.843 |
| 07/06/1993 | 35,56 | 37,43 | 34,62 | 34,62 | -2,63% | 7,89% | 1.095 |
| 04/06/1993 | 37,43 | 38,37 | 35,56 | 35,56 | -5,00% | 7,50% | 5.423 |
| 03/06/1993 | 39,30 | 39,30 | 37,43 | 37,43 | +0,00% | 4,76% | 2.217 |
| 02/06/1993 | 39,30 | 39,30 | 37,43 | 37,43 | -4,76% | 4,76% | 214 |
| 01/06/1993 | 39,30 | 39,30 | 39,30 | 39,30 | +5,00% | 0,00% | 214 |
| 28/05/1993 | 37,43 | 37,90 | 37,43 | 37,43 | -4,76% | 1,25% | 20.625 |
| 27/05/1993 | 39,30 | 39,30 | 37,43 | 39,30 | +0,00% | 4,76% | 347 |
| 26/05/1993 | 39,30 | 39,30 | 37,43 | 39,30 | +0,00% | 4,76% | 3.153 |
| 25/05/1993 | 37,43 | 39,30 | 37,43 | 39,30 | +5,00% | 5,00% | 2.618 |
| 24/05/1993 | 37,43 | 40,24 | 37,43 | 37,43 | +0,00% | 7,50% | 5.477 |
| 21/05/1993 | 37,43 | 38,37 | 37,43 | 37,43 | +0,00% | 2,50% | 3.500 |
| 20/05/1993 | 37,43 | 40,24 | 37,43 | 37,43 | -6,98% | 7,50% | 401 |
| 19/05/1993 | 39,30 | 40,24 | 37,43 | 40,24 | +1,18% | 7,14% | 4.836 |
| 18/05/1993 | 32,75 | 40,24 | 32,75 | 39,77 | +18,06% | 22,86% | 13.412 |
| 17/05/1993 | 32,75 | 35,56 | 32,75 | 33,69 | +2,86% | 8,57% | 3.446 |
| 14/05/1993 | 32,75 | 35,56 | 32,75 | 32,75 | -4,11% | 8,57% | 1.496 |
| 13/05/1993 | 32,75 | 35,56 | 32,75 | 34,15 | -3,95% | 8,57% | 7.962 |
| 12/05/1993 | 35,56 | 35,56 | 32,75 | 35,56 | +5,56% | 7,89% | 1.363 |
| 11/05/1993 | 35,56 | 35,56 | 32,75 | 33,69 | -5,26% | 7,89% | 1.550 |
| 10/05/1993 | 32,75 | 35,56 | 32,75 | 35,56 | +5,56% | 8,57% | 481 |